Renal Dysfunction Raises Risk of Vertebral Fractures in T2DM Patients

Written By :  Dr Riya Dave
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-07-04 16:30 GMT   |   Update On 2025-07-04 16:30 GMT
Advertisement

Researchers have demonstrated that renal impairment highly increases the risk of vertebral fracture among type 2 diabetes mellitus (T2DM) patients, according to data from a five-year longitudinal follow-up study. The research showed specific types of renal impairment such as low estimated glomerular filtration rate (eGFR) and proteinuria to be independently associated with a high fracture risk. These findings emphasize the need for closer follow-up and preventive measures for bone health in diabetic patients presenting with evidence of kidney disease. The study was published in Diabetes, Metabolic Syndrome and Obesity by Nandong Hu and colleagues.

Advertisement

T2DM is a proven risk factor for both chronic kidney disease and decreased bone mineral density. Vertebral fractures (VFs), typically silent but clinically significant, are more prevalent in this population. However, the direct longitudinal association between kidney impairment and vertebral fracture risk has rarely been explored. This study attempted to fill that gap by exploring the influence of different manifestations of renal dysfunction decrease in eGFR, proteinuria, or both on the risk of vertebral fractures in older persons with T2DM.

The research enrolled T2DM patients aged 50 years and older with no baseline vertebral fractures identified on CT imaging between January 2019 and December 2021. The cohort was monitored yearly until January 2024. Vertebral fractures were defined according to the Genant score system. Patients were stratified on renal function in three categories: no renal dysfunction, eGFR decrease or proteinuria, and eGFR decrease + proteinuria. 135 patients developing new vertebral fractures were identified and matched with 270 control non-fracture patients, on follow-up time and body mass index. Associations were tested with Cox proportional hazards models.

Key Findings

  • 135 patients developed new vertebral fractures with a median follow-up of 2 years.

Renal dysfunction substantially raised fracture risk:

  • eGFR decline or proteinuria: Adjusted Hazard Ratio (HR) = 1.98, 95% CI: 1.35–2.92

  • eGFR decline + proteinuria: Adjusted HR = 2.53, 95% CI: 1.30–4.92

  • Decreased bone CT attenuation (HU) was also associated with fracture risk: Adjusted HR = 0.97, 95% CI: 0.99–0.99

Subgroup analysis demonstrated that this correlation was more pronounced in:

  • Women

  • Non-diabetic neuropathy patients

  • Non-vascular complication patients

  • Non-insulin therapy patients

Adding renal dysfunction enhanced prediction models:

  • AUC increased from 0.817 (95% CI: 0.78–0.85) to 0.839 (95% CI: 0.80–0.87) (p < 0.05)

This longitudinal analysis concludes that renal dysfunction is a standalone risk factor for vertebral fractures among type 2 diabetic patients. Incorporating renal markers like eGFR deterioration and proteinuria greatly enhanced the performance of clinical models to predict fracture risk.

Reference:

Hu, N., Zhang, Y., Wei, Z., Yu, R., Zhang, Y., & Chen, X. (2025). Associations between renal dysfunction subtypes and vertebral fracture in patients with type 2 diabetes: A longitudinal study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 18, 1915–1924. https://doi.org/10.2147/dmso.s522430


Tags:    
Article Source : Diabetes Metabolic Syndrome and Obesity

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Medical Bulletin 04/Jul/2025

Medical Bulletin 03/Jul/2025